Some prominent triptorelin market players include
Many of these companies are emphasizing partnership and collaborations to expand their industry influence. Citing an instance, Amneal Pharmaceuticals, an American pharma company, announced a long-term partnership agreement with Orion Corporation, a Finnish pharma company in January 2023, to commercialize many of Amneal’s complex generic products.
Through this agreement, the company’s complex generic programs will be displayed by Orion in New Zealand, Australia, and most parts of Europe. It will help the company reinforce its product portfolio in Europe.